This week sees people on the move at INC Research, Novasep, Quintiles and beyond. Plus, we find out which CMO is hiring the inventor of Rituxan.
Contract research organisation INC Research has appointed two senior executives to its oncology team.
Asli Turkes becomes VP, clinical development and oncology, while Susan Timoney joins the company as Executive Director, clinical development and oncology.
Turkes is experienced in developing drugs from preclinical to Phase IV stages and beyond, having helped develop an orphan drug for Gaucher’s disease, and a monoclonal antibody class drug for breast cancer.
Timoney is a specialist in the research of solid and haematological tumours. For the last two years, she has led a company-wide initiative to transform project delivery at Quintiles.
Turkes will be based in INC's office in Camberley, while Timoney will work at its Scottish labs.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
From a new administration under president-elect Donald Trump, to continued consolidation, the CRO and CMO industry can...
As 2016 comes to a close, Outsourcing-Pharma.com looks back at some of the major mergers and acquisitions...
Quintiles has opened the global Solution Design Studio at its campus in Research Triangle Park in North...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...